For over 30 years now CNT has been the world's largest supplier of highly purified tobacco-derived Nicotine to the pharmaceutical industry. In recent years CNT has also emerged as a significant supplier of pharmaceutical grade Nicotine to the expanding e-cigarette industry. The processing is done in Switzerland by CNT's exclusive contract manufacturer Siegfried AG under full pharmaceutical cGMP. Our Nicotine is filed and referenced for pharmaceutical use in almost every country of the world. This is achieved through the numerous governmental inspections of Siegfried's facilities by the health authorities of these countries including the US FDA.
Through its integrated supply chain, CNT controls every step of production to ensure that the products integrity is not compromised. In addition to the highest possible quality standards, we focus on regulatory compliance and security of supply with attractive pricing. To date, CNT has produced and delivered more than 1000 tons of Nicotine USP/PhEur. Our manufacturing process and analytical methods are fully validated resulting in a uniform quality of crystal clear Nicotine for every batch produced. As a family-owned company, we are in a position to think and act free from short-term interests. We think and operate with a global outlook due to the company's coverage, knowledge, and experience from our multinational tobacco operations. CNT strives to improve quality, productivity, and innovation across all our business while continuing to invest in the future of the company. For the foremost production and the supply of Nicotine Contraf-Nicotex-Tobacco GmbH (CNT) is leading the way through quality, compliance, attractive pricing and security of supply.